Magavi S S, Macklis J D
Division of Neuroscience, Children's Hospital, Department of Neurology and Program in Neuroscience, Harvard Medical School, Boston, MA 02115, USA.
Neuropsychopharmacology. 2001 Dec;25(6):816-35. doi: 10.1016/S0893-133X(01)00357-8.
Over the past three decades, research exploring potential neuronal replacement therapies have focused on replacing lost neurons by transplanting cells or grafting tissue into diseased regions of the brain. Over most of the past century of modern neuroscience, it was thought that the adult brain was completely incapable of generating new neurons. However, in the last decade, the development of new techniques has resulted in an explosion of new research showing that neurogenesis, the birth of new neurons, normally occurs in two limited and specific regions of the adult mammalian brain, and that there are significant numbers of multipotent neural precursors in many parts of the adult mammalian brain. Recent findings from our lab demonstrate that it is possible to induce neurogenesis de novo in the adult mammalian brain, particularly in the neocortex where it does not normally occur, and that it may become possible to manipulate endogenous multipotent precursors in situ to replace lost or damaged neurons. Elucidation of the relevant molecular controls may allow the development of neuronal replacement therapies for neurodegenerative disease and other CNS injuries that do not require transplantation of exogenous cells.
在过去三十年中,探索潜在神经元替代疗法的研究主要集中在通过将细胞移植或组织移植到大脑病变区域来替代丢失的神经元。在现代神经科学过去的大半个世纪里,人们一直认为成人大脑完全无法产生新的神经元。然而,在过去十年中,新技术的发展引发了大量新研究,这些研究表明神经发生,即新神经元的产生,通常发生在成年哺乳动物大脑的两个有限且特定的区域,并且在成年哺乳动物大脑的许多部位存在大量多能神经前体细胞。我们实验室最近的研究结果表明,有可能在成年哺乳动物大脑中从头诱导神经发生,特别是在正常情况下不会发生神经发生的新皮层,并且有可能原位操纵内源性多能前体细胞来替代丢失或受损的神经元。阐明相关的分子控制机制可能会推动针对神经退行性疾病和其他中枢神经系统损伤的神经元替代疗法的发展,而这些疗法无需移植外源细胞。